Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Unknown 3Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prediabetic State 1Neoplasms 1Diabetes Mellitus, Type 2 1Diabetes Mellitus, Type 1 1Diabetes Mellitus 1Colorectal Neoplasms 1

Interventions

Exercise 59Radiotherapy 49Blood Specimen Collection 45Radiosurgery 37Drug Therapy 35Standard of Care 32Surgical Procedures, Operative 30Magnetic Resonance Spectroscopy 26Laparoscopy 24Cisplatin 24Cyclophosphamide 23Control Groups 23Biopsy 23Acupuncture Therapy 23Magnetic Resonance Imaging 20Saline Solution 19Radiofrequency Ablation 19Endoscopic Mucosal Resection 19camrelizumab 16Surveys and Questionnaires 16Propofol 16Metformin 16Cytarabine 16anlotinib 15Preoperative Exercise 15Injections 15Fluorouracil 15Radiotherapy, Intensity-Modulated 14Neoadjuvant Therapy 14Early Intervention, Educational 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Unknown × Continuous Glucose Monitoring × Clear all
NCT05998460 2023-12-21

GET CHARGED

Georgetown University

Phase NA Unknown
100 enrolled

Prediabetic State

NCT06011473 2023-08-31

CGM-CRC

Medical University of Gdansk

Phase NA Unknown
40 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT04942756 2021-07-22

GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients.

Antea Foundation

Phase NA Unknown
118 enrolled

Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡